Volume 25, Issue 1 (Avicenna Journal of Clinical Medicine - Spring 2018)                   Avicenna J Clin Med 2018, 25(1): 28-34 | Back to browse issues page


XML Persian Abstract Print


1- Assistant Professor, Department of Microbiology, School of Basic Sciences, Kazerun Branch, Islamic Azad University, Kazerun, Iran , afsoonsh1980@yahoo.com
2- PhD Student, Department of Microbiology School of Basic Sciences, Kazerun Branch, Islamic Azad University, Kazerun, Iran
Abstract:   (4843 Views)
Background and Objective: Pseudomonas aeroginosa is the most common pathogen associated with nosocomial infections and possesses virulence factors which contribute to the bacterial invasion and toxicity such as alginate, exoenzyme S, exotoxin A and elastase. The aim of this study was to determine the prevalence of algD, exoS, toxA and lasB genes in Pseudomonas aeruginosa samples isolated from patients by Multiplex PCR.
Materials and Methods: In this cross sectional study, sixty clinical samples were collected from Dey and Motahhari Hospitals, Tehran, Iran. Following identification of isolates by biochemical methods, Antibiogram test was performed using disc diffusion method with different antibiotics. Multiplex PCR method was performed to identify the desired genes.
Results: 37 out of 60 (61.66%) male and 23 out of 60 (38.34%) female specimens were positive for pseudomonas aeruginosa. The highest level of antibiotic resistance of the Pseudomonas aeroginosa isolates was observed against ceftriaxone (93.33%). The prevalence rate of virulence genes among all isolates was as follows; lasB (61.7%), toxA (60%), algD (43.3%) and exoS (5%).
Conclusion: Elastase, exotoxin A and alginate are considered important virulence factors of pseudomonas aeruginosa and they play a major role in causing diseases and tissue and skin lesions.
Full-Text [PDF 679 kb]   (1490 Downloads)    
Type of Study: Original |

References
1. Khan AA, Cerniglia CE. Detection of Pseudomonas aeruginosa from clinical and environmental samples by amplification of the exotoxin A gene using PCR. Appl Environ Microbiol. 1994;60(10):3739-45. [PubMed]
2. Ramsey DM, Wozniak DJ. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol. 2005;56(2):309-22. [DOI] [PubMed]
3. Stonehouse MJ, Cota‐Gomez A, Parker SK, Martin WE, Hankin JA, Murphy RC, et al. A novel class of microbial phosphocholine‐specific phospholipases C. Mol Microbiol. 2002;46(3):661-76. [PubMed]
4. Najafimosleh M, Rashnotaie S, Ghaznavirad E, Abtahi H, Taleie G. Designing of the specific DNA primers for detection of the exoA, oprL and algD pathogenicity genes for rapid diagnosis of Pseudomonas aeruginosa. Tehran Univ Med J. 2013;71(8):493-501. [Persian]
5. Zhu H, Conibear TC, Bandara R, Aliwarga Y, Stapleton F, Willcox MD. Type III secretion system–associatedtoxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res. 2006;31(4):297-306. [DOI] [PubMed]
6. Amini Bezanjanii F, Mahmoudi R, Amini K. Study and identification Quorum Sensing (QS) genes of Pseudomonas aeruginosa strains isolated from samples of human clinical by Multiplex PCR and determine antibiotic resistance. Yafteh. 2016;18(2):38-44. [Persian]
7. Wikler MA. Performance standards for antimicrobial disk susceptibility tests: approved standard: Clin Lab Stand Inst. 2006;26(3):1-183.
8. Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar-Lari A, Goudeau A, et al. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from otherorigins. J Med Microbiol. 2004;53(1):73-81. [DOI] [PubMed]
9. Zaranza AV, Morais FC, do Carmo MS, de Mendonça Marques A, Andrade-Monteiro C, Ferro TF, et al. Antimicrobial susceptibility, biofilm production and adhesion to HEp-2 cells of Pseudomonas aeruginosa strains isolated from clinical samples. J Biomat Nanobiotechnol. 2013;4(1):98.
10. Vaez H, Faghri J, Nasr Esfahani B, Moghim S, Fazeli H, Sedighi M, et al. Antibiotic resistance patterns and genetic diversity in clinical isolatesof pseudomonas aeruginosa isolated from patients of a referral hospital, Isfahan, Iran. Jundishapur J Microbiol. 2015;8(8):e20130. [DOI] [PubMed]
11. Nikbin VS, Aslani MM, Sharafi Z, Hashemipour M, Shahcheraghi F, Ebrahimipour G. Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins. Iran J Microbiol. 2012;4(3):118-23. [PubMed]
12. Ranjbar R, Owlia P, Saderi H, Mansouri S, Jonaidi-Jafari N, Izadi M, et al. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran. Acta Med Iran. 2011;49(10):675-9. [PubMed]
13. Ahmadi A, Soltanpour MM, Imani Fooladi AA. Prevalency of imipenem-resistant bacterial strains isolated from hospital and accuracy of Iranian imipenem disc product. J Gorgan Univ Med Sci. 2015;17(1):61-6. [Persian]
14. López-Causapé C, de Dios-Caballero J, Cobo M, Escribano A, AsensioÓ, Oliver A, et al. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study. Int J Antimicrob Agents. 2017;50(3):334-41. [DOI] [PubMed]
15. Fazeli H, Akbari R, Moghim S, Asadian A, Faghihinia J, Saneeyan H, et al. Detection of morphotyping characteristics identification antibiotic resistance of Pseudomonas ‎aeruginosa isolated from patients with cystic fibrosis. J Isfahan Med Sch. 2012;29(171):‎1-12‎.
16. Khalaji Y, Doosti A, Ghorbani-Dalini S. Molecular evaluation of antibiotic resistance prevalence in Pseudomonas aeroginosa isolated from cockroaches in Southwest Iran. Int J Med Med Sci. 2013;5(9):420-4.
17. Azargoon R, Doustdar F, Khanbabaei G, Mehrnejad F, Goudarzi H. Type III secretion system characterization of Pseudomonas aeruginosa associated with cystic fibrosis. Res Med. 2013;37(3):189-93. [Persian]
18. Golshani Z, Ahadi AM, Sharifzadeh A. Antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolated from patients referring to hospitals. Arch Hyg Sci. 2012;1(2):48-53. [Persian]
19. Kamali A, Amini K. Concurrent isolation of virulence genes ETA, oprL, gyrB in Pseudomonas aeruginosa clinical samples from hospitals in Kerman by Multiplex-PCR. J Shahrekord Univ Med Sci. 2016;18(3):48-56. [Persian]
20. Ra'oof WaM. Distribution of algD, lasB, pilB and nan1 genes among MDR clinical isolates of Pseudomonas aeruginosa in respect to site of infection. Tikrit Med J. 2011;17(2):148-60.
21. Valadbeigi H, Sadeghifard N, Rafiei TR, Maleki A. A study on the frequency of toxin A, Alginate genes, and of clinical Pseudomonas aeroginosastrains. J Ilam Univ Med Sci. 2011;20(1):58-64. [Persian]
22. Wolska K, Szweda P. Genetic features of clinical Pseudomonas aeruginosa strains. Pol J Microbiol. 2009;58(3):255-60. [PubMed]
23. Dadmanesh M, Pilehvarzadeh M, Eramabadi M, Eramabadi P, Bagheri Moghadam M, Mashayekhi F. Community acquired Pseudomonas aeroginosaurinary tract infections in children hospitalized in a Baqiatallah hospital, Tehran, Iran: Virulence profile and antibiotic resistance properties. Biosci Biotech Res Asia. 2014;11(2):417-26.
24. Faraji F, Mahzounieh M, Ebrahimi A, Fallah F, Teymournejad O, Lajevardi B. Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran. Microb Pathog. 2016;99:1-4. [DOI] [PubMed]
25. Fadhil L, Al-Marzoqi AH, Al Taee ZM, Shalan AA. Molecular and phenotypic study of virulence genes in a pathogenic strain of Pseudomonas aeruginosaisolated from various clinical origins by PCR: profiles of genes and toxins. Res J Pharm Biol Chem Sci. 2016;7(1):590-8.
26. Abd El-Tawab AA, El-Hofy F, Khater DF, Al-Adl MM. Virulence, resistance genes detection and sequencing of gyrAGene of Pseudomonas aeruginosa isolated from chickens and human in Egypt. Nat Sci. 2018;16(2):32-9.
27. Ataee-Ashtiani M Z-ST. Molecular detection of the genes gyrB, oprL, ETA, 16SrDNA in Pseudomonas aeruginosastrains isolated from clinical samples of Karaj city health centers, Iran. J Isfahan Med Sch. 2016;33(360):2043-8. [Persian]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.